- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about ICUI
Recent news which mentions ICUI
ICU Medical Earnings Perspective: Return On Capital Employed
March 02, 2023
Tickers
ICUI
From Benzinga
Earnings Scheduled For February 27, 2023
February 27, 2023
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 8, 2022
November 08, 2022
From Benzinga
From Benzinga
FDA Signals Shortage Of ICU Medical's Tracheostomy Tubes
November 01, 2022
Tickers
ICUI
From Benzinga
From Benzinga
From Benzinga
Why Verona Pharma Is Trading Higher By Around 84%, Here Are 85 Stocks Moving In Tuesday's Mid-Day Session
August 09, 2022
From Benzinga
Karuna Therapeutics To $276? Plus SVB Leerink Almost Doubles Price Target On This Stock
August 09, 2022
From Benzinga
This Analyst Lowers Price Target On Lyft; Also Check Out Some Other Major PT Changes
August 08, 2022
From Benzinga
From Benzinga
10 Biggest Price Target Changes For Tuesday
May 10, 2022
From Benzinga
From Benzinga
The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company
February 24, 2022
From Benzinga
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
February 20, 2022
From Benzinga
The Daily Biotech Pulse: Glaukos Gets FDA Nod, Neurocrine Preannounces Soft Ingrezza Sales, 3 IPOs
January 07, 2022
From Benzinga
ICU Medical, inc (ICUI) Q3 2021 Earnings Call Transcript
November 03, 2021
Tickers
ICUI
From Motley Fool
The Daily Biotech Pulse: Cerus Climbs On Earnings, Horizon CFO To Retire, Teva Prices Upsized Sustainability-Linked Senior Note Offering
November 03, 2021
From Benzinga
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
October 31, 2021
From Benzinga
From Benzinga
10 Biggest Price Target Changes For Thursday
September 09, 2021
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.